Andrew Guggenhime
Chief Financial Officer, NEOFORMA INC.
Companies
- Caribou Biosciences, Inc.Board member Jul 22, 2021 to now1
- Vaxcyte, Inc.President Apr 6, 2021 to now2
- Vaxcyte, Inc.Chief financial officer Jun 11, 2020 to now3
- Metacrine, Inc.Board member Sep 15, 2020 to Sep 6, 20224
- Dermira (United States)Chief financial officer Oct 2, 2014 to Feb 24, 20205
- Dermira (United States)Chief operating officer Oct 2, 2014 to Aug 17, 20185
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Vaxcyte, Inc. PCVX157,166 shares6$10.3M at $65.22Sep 9, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 8, 2026Shares withheld for tax 7,155 shares at $60.36 of Vaxcyte, Inc.6
- Sep 2, 2026Shares withheld for tax 1,432 shares at $61.58 of Vaxcyte, Inc.7
- Aug 31, 2026Shares withheld for tax 1,273 shares at $60.74 of Vaxcyte, Inc.7
- Aug 3, 2026Sold 3,044 shares at $54.18 of Vaxcyte, Inc.8
- Aug 3, 2026Sold 6,956 shares at $53.76 of Vaxcyte, Inc.8
- Aug 3, 2026Exercised options 10,000 shares at $5.35 of Vaxcyte, Inc.8
- Jul 6, 2026Sold 2,087 shares at $57.76 of Vaxcyte, Inc.9
- Jul 6, 2026Sold 7,913 shares at $57.16 of Vaxcyte, Inc.9
- Jul 6, 2026Exercised options 10,000 shares at $5.35 of Vaxcyte, Inc.9
- Jun 18, 2026Sold 10,000 shares at $53.00 of Vaxcyte, Inc.10
- Jun 18, 2026Exercised options 10,000 shares at $5.35 of Vaxcyte, Inc.10
- Mar 9, 2026Shares withheld for tax 1,021 shares at $59.32 of Vaxcyte, Inc.11
- Mar 2, 2026Shares withheld for tax 1,009 shares at $61.98 of Vaxcyte, Inc.12
- Feb 28, 2026Shares withheld for tax 898 shares at $61.98 of Vaxcyte, Inc.12
- Feb 26, 2026Granted 44,864 shares of Vaxcyte, Inc.12
- Jan 14, 2026Gift 61,850 shares of Vaxcyte, Inc.13
- Jan 14, 2026Gift 61,850 shares of Vaxcyte, Inc.13
- Sep 8, 2025Shares withheld for tax 2,890 shares at $32.41 of Vaxcyte, Inc.14
- Sep 2, 2025Shares withheld for tax 1,429 shares at $31.56 of Vaxcyte, Inc.15
- Sep 2, 2025Shares withheld for tax 2,381 shares at $31.56 of Vaxcyte, Inc.15
- Sep 2, 2025Shares withheld for tax 1,270 shares at $31.56 of Vaxcyte, Inc.15
- Apr 7, 2025Exercised options 4,777 shares at $20.93 of Vaxcyte, Inc.16
- Mar 3, 2025Shares withheld for tax 3,809 shares at $72.10 of Vaxcyte, Inc.17
- Feb 28, 2025Shares withheld for tax 1,270 shares at $73.02 of Vaxcyte, Inc.17
- Feb 27, 2025Granted 22,761 shares of Vaxcyte, Inc.17
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARVaxcyte, Inc., President
- 3
- 4SEC EDGARMetacrine, Inc., Board member
- 5
- 6
- 7SEC EDGARForm 4 filed Sep 2, 2026
- 8SEC EDGARForm 4 filed Aug 5, 2026
- 9SEC EDGARForm 4 filed Jul 6, 2026
- 10SEC EDGARForm 4 filed Jun 18, 2026
- 11SEC EDGARForm 4 filed Mar 11, 2026
- 12SEC EDGARForm 4 filed Mar 2, 2026
- 13SEC EDGARForm 4 filed Jan 16, 2026
- 14SEC EDGARForm 4 filed Sep 10, 2025
- 15SEC EDGARForm 4 filed Sep 4, 2025
- 16SEC EDGARForm 4 filed Apr 9, 2025
- 17SEC EDGARForm 4 filed Mar 3, 2025